Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Irbesartan + Hydrochlorothiazide
- Therapeutic area
- Cardiovascular
- Drug class
- Angiotensin receptor blockers
- ATC
- C09CA
- Strength
- 300 mg + 12.5 mg
- Dosage form
- Tablet
- Pack
- 10's
- Registration no.
- 103386
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-25 03:02
Manufacturer
De-Mont Research Laboratories (Pvt.) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (10's). Current price PKR 393.44, effective 1 Jul 2025.
Cite this price history
MedInfoBase. Irbival-H 300 300 mg + 12.5 mg, 10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/irbival-h-300-300-mg-12-5-mg-103386-10s-de-mont-research-laboratories-pvt-ltd/ (accessed 25 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 393.44 | 2025-07-01 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 103386Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.
